ANI PHARMACEUTICALS INC
ANIP
DELAYED 1 MONTH
24 insider filings · Latest: Jul 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Jul 30 8:02 PM | Stephen P. CareySVP & CFO | Sale | 2,850 | $81.36 | $231.9K | 174,693(D) | View → |
| Jun 8, 2026 | Jun 11 1:06 AM | Thomas HaugheyDirector | Sale | 2,000 | $80.88 | $161.8K | 38,878(D) | View → |
| Jun 5, 2026 | Jun 9 10:33 PM | Stephen P. CareySVP & CFO | Sale | 3,312 | $80.00 | $265.0K | 180,393(D) | View → |
| May 13, 2026 | May 14 12:22 AM | Patrick D WalshDirector | Sale | 10,000 | $80.63 | $806.3K | 38,432(D) | View → |
| May 11, 2026 | May 14 12:22 AM | Patrick D WalshDirector | Sale | 3,973 | $80.75 | $320.8K | 48,432(D) | View → |
| May 12, 2026 | May 13 8:16 PM | Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDS | Sale | 459 | $79.21 | $36.4K | 38,271(D) | View → |
| May 11, 2026 | May 13 8:16 PM | Nikhil LalwaniDirector, PRESIDENT & CEO | Sale | 55,000 | $77.57 | $4.3M | 349,889(D) | View → |
| May 12, 2026 | May 13 8:15 PM | Ori GutwergSVP, GENERICS | Sale | 2,772 | $79.50 | $220.4K | 78,696(D) | View → |
| May 13, 2026 | May 13 8:15 PM | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $78.16 | $39.1K | 78,390(D) | View → |
| Mar 11, 2026 | Mar 13 9:28 PM | Thomas Andrew RowlandSVP, HEAD - ESTABLISHED BRANDS | Sale | 4,772 | $74.91 | $357.5K | 38,730(D) | View → |
| Mar 13, 2026 | Mar 13 9:28 PM | Christopher MutzHEAD OF RARE DISEASE | Sale | 3,162 | $71.64 | $226.5K | 91,309(D) | View → |
| Mar 13, 2026 | Mar 13 9:28 PM | Meredith CookSR. VP, GENERAL COUNSEL & SEC. | Sale | 500 | $72.62 | $36.3K | 79,390(D) | View → |
| Mar 9, 2026 | Mar 10 8:09 PM | Christopher MutzHEAD OF RARE DISEASE | Sale | 3,602 | $74.18 | $267.2K | 94,471(D) | View → |
| Mar 6, 2026 | Mar 10 8:09 PM | Christopher MutzHEAD OF RARE DISEASE | Sale | 2,121 | $74.22 | $157.4K | 101,387(D) | View → |
| Mar 9, 2026 | Mar 10 8:06 PM | Krista DavisSVP, CHIEF HR OFFICER | Sale | 5,087 | $74.13 | $377.1K | 51,946(D) | View → |
| Mar 6, 2026 | Mar 10 8:06 PM | Krista DavisSVP, CHIEF HR OFFICER | Sale | 1,485 | $75.00 | $111.4K | 57,033(D) | View → |
| Mar 5, 2026 | Mar 5 10:46 PM | Stephen P. CareySVP & CFO | Sale | 7,312 | $75.50 | $552.0K | 185,543(D) | View → |
| Mar 2, 2026 | Mar 4 11:46 PM | Christopher MutzHEAD OF RARE DISEASE | Sale | 417 | $74.00 | $30.9K | 103,508(D) | View → |
| Mar 3, 2026 | Mar 4 11:45 PM | Ori GutwergSVP, GENERICS | Sale | 2,060 | $76.50 | $157.6K | 84,782(D) | View → |
| Mar 3, 2026 | Mar 3 11:01 PM | Patrick D WalshDirector | Sale | 6,000 | $74.23 | $445.4K | 52,405(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 9 10:33 PM | Stephen P. CareySVP & CFO | Option Exercise | 3,312 | $49.51 | 6,626(D) | View → |
| Mar 5, 2026 | Mar 5 10:46 PM | Stephen P. CareySVP & CFO | Option Exercise | 3,312 | $49.51 | 9,938(D) | View → |